Found: 11
Select item for more details and to access through your institution.
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 444, doi. 10.1111/j.1365-2036.2009.04055.x
- By:
- Publication type:
- Article
Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 423, doi. 10.1111/j.1365-2036.2009.04056.x
- By:
- Publication type:
- Article
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 459, doi. 10.1111/j.1365-2036.2009.04064.x
- By:
- Publication type:
- Article
Systematic review: hepatitis-associated aplastic anaemia – a syndrome associated with abnormal immunological function.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 436, doi. 10.1111/j.1365-2036.2009.04060.x
- By:
- Publication type:
- Article
Predictors of health-related quality of life in patients with chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 469, doi. 10.1111/j.1365-2036.2009.04061.x
- By:
- Publication type:
- Article
Reflux patterns in patients with short-segment Barrett’s oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 508, doi. 10.1111/j.1365-2036.2009.04063.x
- By:
- Publication type:
- Article
The pharyngeal mucosa is not involved in eosinophilic oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 495, doi. 10.1111/j.1365-2036.2009.04059.x
- By:
- Publication type:
- Article
Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 487, doi. 10.1111/j.1365-2036.2009.04065.x
- By:
- Publication type:
- Article
Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 477, doi. 10.1111/j.1365-2036.2009.04066.x
- By:
- Publication type:
- Article
The use of exclusive enteral nutrition for induction of remission in children with Crohn’s disease demonstrates that disease phenotype does not influence clinical remission.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 501, doi. 10.1111/j.1365-2036.2009.04067.x
- By:
- Publication type:
- Article
Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy – a randomized crossover study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 5, p. 452, doi. 10.1111/j.1365-2036.2009.04068.x
- By:
- Publication type:
- Article